Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactulose for intestinal dysfunction in moderately severe acute pancreatitis
ChiCTR1900027493Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Nanchang University
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of lactulose in acute pancreatitis (AP) (2 arms), sponsored by First Affiliated Hospital of Nanchang University. Primary endpoints: Improvement degree of gastrointestinal function injury score, Analysis of intestinal flora and its metabolites SCFAs and 2 more. Started Nov 2019; status: recruiting.
02
Drugs
lactulose
03
Conditions
acute pancreatitis (AP)
Beyond the preview
Go deeper on ChiCTR1900027493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900027493.